So, repotrectinib is this inhibitor thing that goes after TRK/ROS1/ALK kinases, which is super helpful for dealing with ROS1-positive NSCLC and NTRK-fusion cancers. And it comes in these 40 mg capsule things.
You’re supposed to take 160 mg once a day for the first two weeks, then switch to 160 mg twice a day after that. It’s sold in bottles that hold 60 capsules.
